Evidence map›Paper›PMID 38020912›Full record

ReviewFrontiers in cell and developmental biology2023

Mechanobiology in oncology: basic concepts and clinical prospects.

Michelle B Chen, Yousef Javanmardi, Somayeh Shahreza, Bianca Serwinski, Amir Aref, Boris Djordjevic, Emad Moeendarbary

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Mechanical signatures in cancer metastasis.npj biological physics and mechanics · 2025
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michelle B Chen *Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.
Yousef Javanmardi *Department of Mechanical Engineering, University College London, London, United Kingdom.
Somayeh ShahrezaDepartment of Mechanical Engineering, University College London, London, United Kingdom.
Bianca SerwinskiDepartment of Mechanical Engineering, University College London, London, United Kingdom.
Amir ArefBelfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
Boris DjordjevicDepartment of Mechanical Engineering, University College London, London, United Kingdom.
Emad MoeendarbaryDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.

Funding

Wellcome Trust
6 · The paper itself

Abstract

The interplay between genetic transformations, biochemical communications, and physical interactions is crucial in cancer progression. Metastasis, a leading cause of cancer-related deaths, involves a series of steps, including invasion, intravasation, circulation survival, and extravasation. Mechanical alterations, such as changes in stiffness and morphology, play a significant role in all stages of cancer initiation and dissemination. Accordingly, a better understanding of cancer mechanobiology can help in the development of novel therapeutic strategies. Targeting the physical properties of tumours and their microenvironment presents opportunities for intervention. Advancements in imaging techniques and lab-on-a-chip systems enable personalized investigations of tumor biomechanics and drug screening. Investigation of the interplay between genetic, biochemical, and mechanical factors, which is of crucial importance in cancer progression, offers insights for personalized medicine and innovative treatment strategies.

Indexed as

cancerextracellular matrix (ECM)invasionmechanobiolgymechanotherapeuticsmetastasis (cancer metastasis)

Identifiers

PMID38020912
PMCPMC10644154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.